April 19, 2023
1 min read
Save
FREEDOM COVID
Issue: April 2023

Determining the safety of enoxaparin and apixaban (Eliquis, Bristol Myers Squibb/Pfizer) in patients hospitalized but not intubated with confirmed COVID-19.